These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29353972)

  • 21. Optimal positive cutoff points for careHPV testing of clinician- and self-collected specimens in primary cervical cancer screening: an analysis from rural China.
    Kang LN; Jeronimo J; Qiao YL; Zhao FH; Chen W; Valdez M; Zhang X; Bansil P; Paul P; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
    J Clin Microbiol; 2014 Jun; 52(6):1954-61. PubMed ID: 24671789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cross-sectional study exploring triage of human papillomavirus (HPV)-positive women by visual assessment, manual and computer-interpreted cytology, and HPV-16/18-45 genotyping in Cameroon.
    Vassilakos P; Wisniak A; Catarino R; Tincho Foguem E; Balli C; Saiji E; Tille JC; Kenfack B; Petignat P
    Int J Gynecol Cancer; 2021 Jun; 31(6):808-816. PubMed ID: 33833084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda.
    Umulisa MC; Franceschi S; Baussano I; Tenet V; Uwimbabazi M; Rugwizangoga B; Heideman DAM; Uyterlinde AM; Darragh TM; Snijders PJF; Sayinzoga F; Clifford GM
    BMC Womens Health; 2018 Apr; 18(1):59. PubMed ID: 29699549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.
    Zhao FH; Lin MJ; Chen F; Hu SY; Zhang R; Belinson JL; Sellors JW; Franceschi S; Qiao YL; Castle PE;
    Lancet Oncol; 2010 Dec; 11(12):1160-71. PubMed ID: 21075054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women.
    Bigoni J; Gundar M; Tebeu PM; Bongoe A; Schäfer S; Fokom-Domgue J; Catarino R; Tincho EF; Bougel S; Vassilakos P; Petignat P
    Int J Cancer; 2015 Jul; 137(1):127-34. PubMed ID: 25420434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening.
    Luo H; Belinson JL; Du H; Liu Z; Zhang L; Wang C; Qu X; Pretorius RG; Wu R
    J Low Genit Tract Dis; 2017 Jan; 21(1):12-16. PubMed ID: 27851695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    Song F; Du H; Wang C; Huang X; Wu R;
    PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic accuracy of cervical cancer screening strategies for high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) among women living with HIV: A systematic review and meta-analysis.
    Kelly H; Jaafar I; Chung M; Michelow P; Greene S; Strickler H; Xie X; Schiffman M; Broutet N; Mayaud P; Dalal S; Arbyn M; de Sanjosé S
    EClinicalMedicine; 2022 Nov; 53():101645. PubMed ID: 36187721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of human papilloma virus-DNA test verses colposcopy as secondary cervical cancer screening test to triage screen positive women on primary screening by visual inspection with 5% acetic acid.
    Pimple S; Shastri SS
    Indian J Cancer; 2014; 51(2):117-23. PubMed ID: 25104191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.
    Jentschke M; Soergel P; Hillemanns P
    J Virol Methods; 2013 Oct; 193(1):131-4. PubMed ID: 23707925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
    Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
    Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. At what age should the Uyghur minority initiate cervical cancer screening if screened using careHPV.
    Abulizi G; Mijiti P; Naizhaer G; Tuerxun G; Abuduxikuer G; Zhang YY; Li H; Abulimiti T; Abudurexiti G; Aierken K; Lu L; Maimaiti A
    Cancer Med; 2021 Dec; 10(24):9022-9029. PubMed ID: 34816621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk assessment of self-sampling HPV tests based on PCR, signal amplification to guide the appropriate screening intervals: A prospective study in China.
    Zhao X; Hu S; Zhao S; Rezhake R; Huang L; Duan X; Zhang X; Qiao Y; Arbyn M; Zhao F
    J Natl Cancer Cent; 2022 Dec; 2(4):298-305. PubMed ID: 39036548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A parallel study of careHPV and Hybrid Capture 2 human papillomavirus DNA testing for cervical cancer screening in rural China.
    Lin CQ; Chen F; Liu B; Zhang YZ; Cui XL; Li AM; Zhang WH; Chen W; Chang I; Sivasubramaniam P; Zhu J; Qiao YL
    J Virol Methods; 2014 Jun; 202():73-8. PubMed ID: 24642241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
    Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring an Appropriate Method of Cervical Cancer Screening in Rural China.
    Zhang X; Zhao G; Bi H; Zhou M; Wang X; Juan J
    Asia Pac J Public Health; 2019 Oct; 31(7):652-658. PubMed ID: 31578073
    [No Abstract]   [Full Text] [Related]  

  • 38. [HPV primary test in the cervical cancer screening: reproducibility assessment and investigation on cytological outcome of Hybrid Capture 2 borderline samples].
    Burroni E; Sani C; Bisanzi S; Ocello C
    Epidemiol Prev; 2016; 40(3-4):164-70. PubMed ID: 27436249
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.